- Key Factors Influencing Quality of Liquid Biopsy
- Promotion of Precised Management of Lung Cancer by Liquid Biopsy
- Roles of High Sensitivity Testing in Development & Application of Biomarkers in Cancers
- Discovery, Identification and Clinical Evaluation of Biomarkers in Liquid Biopsy
- Standardization of Clinical Application of Liquid Biopsy
- Liquid Biopsy in High Sensitivity Testing of Cancer Biomarkers
- Indoor Quality Control and Quality Evaluation Between Rooms
- High Sensitivity Quantification of DNA Methylated Derivatives
- Methylation of Specific ctDNA Sites: Early Diagnosis & Treatment and Prognosis of Liver Cancer
- Liquid Biopsy in Monitoring of Cancer Metastasis
- Discussion: Looking into the future, will liquid biopsy be all in one, or only help improve improve the sensitivity and specificity of traditional test methods?
- Tumor Catcher: Polypeptide Nanoparticles for CTC
- Novel Technologies of DNA High Sensitivity Testing
- High Sensitivity Testing in Biosensing
- Accurately Self-Assembly of Nano-Markers and Quantitative Amplification of Weak Biological Signals
- Localization Testing of Circulating Tumor DNA
- Industrialization Process and Periodic Strategies of Liquid Biopsy
- R & D and Application of CytoploRare: A CTC Testing Kit
- Next Generation Digital ctDNA Testing
- Application of Droplet Digital PCR
Key problems in liquid biopsy will be analysed from multiple aspects
Clinical application of liquid biopsy in China will be discussed.
Commercialization of liquid biopsy in China will be facilitated.
Researchers from Institutes on Cancer
Personnels from Clinical Laboratories and Firms Providing the Laboratory Testing
Personnels from Companies on other Aspects like Pharmaceutics, Health Management and Data Processing
Dear Mr./Ms.
You have registered successfully, the registration information and attention has been sent to the contact and the participants of the mailbox, please note that check. If not received, please contact the general meeting